Ding Zhou
Chief Executive Officer at Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
Profile
Ding Zhou is the founder of Zion Pharma Ltd., which he founded in 2018 and where he currently holds the title of Director & Chief Scientific Officer.
He is also currently employed as General Manager & Director at Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
Ding Zhou active positions
| Companies | Position | Start |
|---|---|---|
Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
 Shanghai Zanrong Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Zion Pharma Ltd., Shanghai Zanrong Pharmaceutical Technology Co., Ltd. is a company that develops small molecule anti-tumour drugs. The company is based in Shanghai, China. The Chinese company was founded in 2018. The CEO is Ding Zhou. | Chief Executive Officer | - |
Zion Pharma Ltd.
 Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Founder | 2017-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Zion Pharma Ltd.
Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Commercial Services |
Shanghai Zanrong Pharmaceutical Technology Co., Ltd.
Shanghai Zanrong Pharmaceutical Technology Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Zion Pharma Ltd., Shanghai Zanrong Pharmaceutical Technology Co., Ltd. is a company that develops small molecule anti-tumour drugs. The company is based in Shanghai, China. The Chinese company was founded in 2018. The CEO is Ding Zhou. | Health Technology |
- Stock Market
- Insiders
- Ding Zhou
